We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+16.44%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$13.3B
AUM Growth
+$1.82B
Cap. Flow
+$65.9M
Cap. Flow %
0.5%
Top 10 Hldgs %
32.36%
Holding
350
New
21
Increased
125
Reduced
153
Closed
21

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$72.8M
2
ABBV icon
AbbVie
ABBV
+$59.8M
3
PG icon
Procter & Gamble
PG
+$53.3M
4
VZ icon
Verizon
VZ
+$26.4M
5
AVGO icon
Broadcom
AVGO
+$19.9M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$79.9M
2
MCD icon
McDonald's
MCD
+$64.5M
3
EL icon
Estee Lauder
EL
+$57.4M
4
O icon
Realty Income
O
+$20.5M
5
AAPL icon
Apple
AAPL
+$18.6M

Sector Composition

Rank Sector Weight
1 Technology 21.17%
2 Healthcare 15.36%
3 Financials 13.42%
4 Consumer Staples 9.92%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EPP icon
276
iShares MSCI Pacific ex Japan ETF
EPP
$2.28B
$604K ﹤0.01%
15,180
-125
-0.8% -$4.68K
FIS icon
277
Fidelity National Information Services
FIS
$22.1B
$595K ﹤0.01%
4,437
– –
DHR icon
278
Danaher
DHR
$144B
$593K ﹤0.01%
3,780
-15
-0.4% -$2.15K
TSM icon
279
TSMC
TSM
$2.18T
$567K ﹤0.01%
9,984
+113
+1% +$5.96K
SNX icon
280
TD Synnex
SNX
$20.2B
$560K ﹤0.01%
9,350
-200
-2% -$9.35K
HRL icon
281
Hormel Foods
HRL
$13.8B
$541K ﹤0.01%
11,200
+200
+2% +$9.56K
SPG icon
282
Simon Property Group
SPG
$72.3B
$541K ﹤0.01%
7,918
-161,469
-95% -$10.1M
KSU
283
DELISTED
Kansas City Southern
KSU
$539K ﹤0.01%
3,613
– –
IFF icon
284
International Flavors & Fragrances
IFF
$21.9B
$510K ﹤0.01%
4,167
– –
PYPL icon
285
PayPal
PYPL
$50.5B
$502K ﹤0.01%
2,880
-60
-2% -$8.29K
GSK icon
286
GSK
GSK
$106B
$465K ﹤0.01%
9,129
+547
+6% +$28.1K
HBAN icon
287
Huntington Bancshares
HBAN
$35.5B
$452K ﹤0.01%
49,998
-6,523
-12% -$57.7K
CHRW icon
288
C.H. Robinson
CHRW
$17.5B
$448K ﹤0.01%
5,670
– –
ATVI
289
DELISTED
Activision Blizzard
ATVI
$444K ﹤0.01%
5,845
– –
GE icon
290
GE Aerospace
GE
$384B
$439K ﹤0.01%
12,881
-2,210
-15% -$74.5K
BNY
291
Bank of New York Mellon
BNY
$107B
$437K ﹤0.01%
11,312
-1,400
-11% -$51.2K
HEI icon
292
HEICO Corp
HEI
$51.4B
$424K ﹤0.01%
4,250
-8,581
-67% -$792K
CDK
293
DELISTED
CDK Global, Inc.
CDK
$421K ﹤0.01%
10,153
-1,604
-14% -$61.7K
CME icon
294
CME Group
CME
$94.8B
$403K ﹤0.01%
2,479
-3,845
-61% -$689K
C icon
295
Citigroup
C
$226B
$381K ﹤0.01%
7,461
-1,635
-18% -$77.6K
ATRI
296
DELISTED
Atrion Corp
ATRI
$369K ﹤0.01%
579
-1,950
-77% -$1.28M
DG icon
297
Dollar General
DG
$27.9B
$347K ﹤0.01%
1,822
– –
FTV icon
298
Fortive
FTV
$18.6B
$336K ﹤0.01%
+7,881
New +$307K
DD icon
299
DuPont de Nemours
DD
$19.2B
$332K ﹤0.01%
4,978
-32
-0.6% -$1.87K
CVS icon
300
CVS Health
CVS
$122B
$329K ﹤0.01%
5,061
+366
+8% +$23K
10 11
12
13 14

Similar funds

NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

Bahl & Gaynor's Q2 2020 Portfolio in Review

As of Q2 2020, Bahl & Gaynor held 350 positions worth $13.3B, up 16% from $11.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor's Q2 2020 filing shows 21 new, 125 increased, 153 reduced and 21 closed positions. Its largest new stake was Otis Worldwide: 90,609 shares worth $5.15M. The largest sale was Pfizer, an estimated $79.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q2 2020 buy was Otis Worldwide: 90,609 shares worth $5.15M.
  • Bahl & Gaynor added most to Merck in Q2 2020, an estimated $72.8M increase.
  • Bahl & Gaynor's biggest Q2 2020 reduction was Pfizer, cutting an estimated $79.9M.
  • Bahl & Gaynor fully exited Interparfums in Q2 2020, selling an estimated $4.84M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $13.3B portfolio in Q2 2020.
  • Bahl & Gaynor opened 21 new positions and closed 21 in Q2 2020.
  • Bahl & Gaynor's portfolio value rose 16% quarter-over-quarter to $13.3B.

Based on Bahl & Gaynor's 13F filing for Q2 2020, filed 13 Aug 2020.